These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23469274)

  • 1. Assessment of early tumor response to cytotoxic chemotherapy with dynamic contrast-enhanced ultrasound in human breast cancer xenografts.
    Wang JW; Zheng W; Liu JB; Chen Y; Cao LH; Luo RZ; Li AH; Zhou JH
    PLoS One; 2013; 8(3):e58274. PubMed ID: 23469274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response relationship in cisplatin-treated breast cancer xenografts monitored with dynamic contrast-enhanced ultrasound.
    Chen Y; Han F; Cao LH; Li C; Wang JW; Li Q; Zheng W; Guo ZX; Li AH; Zhou JH
    BMC Cancer; 2015 Mar; 15():136. PubMed ID: 25884471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced US quantitatively detects changes of tumor perfusion in a murine breast cancer model during adriamycin chemotherapy.
    Wang JW; Cao LH; Han F; Zheng W; Chen Y; Li AH; Zhou JH
    Acta Radiol; 2013 Oct; 54(8):882-8. PubMed ID: 23761553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of tumor blood flow changes in a murine breast cancer model after adriamycin chemotherapy using contrast-enhanced destruction-replenishment sonography.
    Wang JW; Zheng W; Chen Y; Cao LH; Luo RZ; Li AH; Zhou JH
    J Ultrasound Med; 2013 Apr; 32(4):683-90. PubMed ID: 23525395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Evaluation of Combretastatin A4 Phosphate Early Efficacy in a Tumor Model with Dynamic Contrast-Enhanced Ultrasound.
    Zhang P; Chen Y; Liu J; Yang Y; Lv Q; Wang J; Zhang L; Xie M
    Ultrasound Med Biol; 2018 Apr; 44(4):840-852. PubMed ID: 29395676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma.
    Dong Y; Qiu Y; Yang D; Yu L; Zuo D; Zhang Q; Tian X; Wang WP; Jung EM
    Clin Hemorheol Microcirc; 2021; 77(4):461-469. PubMed ID: 33459703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Super-Resolution Ultrasound Imaging for Monitoring the Therapeutic Efficacy of a Vascular Disrupting Agent in an Animal Model of Breast Cancer.
    Hoyt K
    J Ultrasound Med; 2024 Jun; 43(6):1099-1107. PubMed ID: 38411352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced Ultrasound in evaluating of angiogenesis and tumor staging of nasopharyngeal carcinoma in nude mice.
    Liang S; Gao Y; Liu Y; Qiu C; Chen Y; Zhu S
    PLoS One; 2019; 14(8):e0221638. PubMed ID: 31442259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases.
    Merz M; Komljenovic D; Semmler W; Bäuerle T
    Invest Radiol; 2012 Jul; 47(7):422-9. PubMed ID: 22659593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+ breast cancer: preliminary results.
    Sorace AG; Quarles CC; Whisenant JG; Hanker AB; McIntyre JO; Sanchez VM; Yankeelov TE
    Breast Cancer Res Treat; 2016 Jan; 155(2):273-84. PubMed ID: 26791520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on breast cancer animal model of tumor-micro vessel variation before and after the chemotherapy by contrast enhanced ultrasound quantitative analysis.
    Zhou SC; Le J; Fan YW; Chen M; Chang C
    Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1407-13. PubMed ID: 27592472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two distinct hereditary hemorrhagic telangiectasia patient subsets with different hepatic perfusion properties by combination of contrast-enhanced ultrasound (CEUS) with perfusion imaging quantification.
    Schelker RC; Andorfer K; Putz F; Herr W; Jung EM
    PLoS One; 2019; 14(4):e0215178. PubMed ID: 30973932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive quantification of tumor vascular architecture during docetaxel-chemotherapy.
    Mahéo K; Chevalier S; Vibet S; Bougnoux P; Richard S; Serrière S; Bleuzen A; Tranquart F; Goupille C
    Breast Cancer Res Treat; 2012 Aug; 134(3):1013-25. PubMed ID: 22438047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts.
    Lindholm EM; Kristian A; Nalwoga H; Krüger K; Nygård S; Akslen LA; Mælandsmo GM; Engebraaten O
    Mol Oncol; 2012 Aug; 6(4):418-27. PubMed ID: 22521242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of real-time gray scale contrast-enhanced ultrasonography with microvessel density and vascular endothelial growth factor expression for assessment of angiogenesis in breast lesions.
    Du J; Li FH; Fang H; Xia JG; Zhu CX
    J Ultrasound Med; 2008 Jun; 27(6):821-31. PubMed ID: 18499842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonic spectrum analysis for in vivo characterization of tumor microstructural changes in the evaluation of tumor response to chemotherapy using diagnostic ultrasound.
    Lin CY; Cao LH; Wang JW; Zheng W; Chen Y; Feng ZZ; Li AH; Zhou JH
    BMC Cancer; 2013 Jun; 13():302. PubMed ID: 23800247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring Dual VEGF Inhibition in Human Pancreatic Tumor Xenografts With Dynamic Contrast-Enhanced Ultrasound.
    Lamuraglia M; Barrois G; Le Guillou-Buffello D; Santin M; Kerbol A; Comperat E; Coron A; Lucidarme O; Bridal SL
    Technol Cancer Res Treat; 2020; 19():1533033819886896. PubMed ID: 32065066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer.
    Amadori M; Barone D; Scarpi E; Oboldi D; Amadori E; Bandi G; Rossi A; Ferroni F; Ragazzini A; Casadei Gardini A; Frassineti GL; Gavelli G; Passardi A
    Eur Radiol; 2018 Jul; 28(7):2969-2978. PubMed ID: 29417252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic liver disease: Quantitative MRI vs CEUS-based microperfusion.
    Haimerl M; Poelsterl S; Beyer LP; Wiesinger I; Nießen C; Stroszczynski C; Wiggermann P; Jung EM
    Clin Hemorheol Microcirc; 2016; 64(3):435-446. PubMed ID: 27858703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic 2-Deoxy-2-[
    Kristian A; Holtedahl JE; Torheim T; Futsaether C; Hernes E; Engebraaten O; Mælandsmo GM; Malinen E
    Mol Imaging Biol; 2017 Apr; 19(2):271-279. PubMed ID: 27541026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.